WO2004037764A1 - Coolant solutions and compositions comprising the sameitle - Google Patents

Coolant solutions and compositions comprising the sameitle Download PDF

Info

Publication number
WO2004037764A1
WO2004037764A1 PCT/CH2003/000703 CH0300703W WO2004037764A1 WO 2004037764 A1 WO2004037764 A1 WO 2004037764A1 CH 0300703 W CH0300703 W CH 0300703W WO 2004037764 A1 WO2004037764 A1 WO 2004037764A1
Authority
WO
WIPO (PCT)
Prior art keywords
menthyl lactate
solvent
solution
menthol carboxamide
weight
Prior art date
Application number
PCT/CH2003/000703
Other languages
French (fr)
Other versions
WO2004037764A8 (en
Inventor
Christophe Galopin
Eduardo Moraes
Lori Tigani
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Priority to CA002497910A priority Critical patent/CA2497910A1/en
Priority to US10/532,514 priority patent/US8093290B2/en
Priority to AU2003271498A priority patent/AU2003271498A1/en
Priority to EP03753207.4A priority patent/EP1556332B1/en
Priority to BRPI0315686-9A priority patent/BR0315686B1/en
Publication of WO2004037764A1 publication Critical patent/WO2004037764A1/en
Publication of WO2004037764A8 publication Critical patent/WO2004037764A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/62—Use of additives, e.g. for stabilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24—Thermal properties
    • A61K2800/244—Endothermic; Cooling; Cooling sensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Definitions

  • This invention is concerned with compositions, and especially solutions comprising menthyl lactate and menthol carboxamide.
  • Menthyl lactate is an important ingredient that is valued for its coolant properties. Furthermore, given its virtual lack of odour and colour, it can be used in all manner of flavour and fragrance compositions to impart an intense and persistent cooling effect without affecting the balance of the fragrance or flavour accord.
  • the crystalline menthyl lactate powder has a tendency to agglomerate. Therefore, for long term storage of the crystal form, it must be kept at relatively low temperatures and under conditions of low humidity.
  • menthyl lactate can be obtained comprising a relative high amount of menthyl lactate, if the menthyl lactate is combined with, or co-dissolved with menthol carboxamide.
  • the present invention provides a method of preparing a solution containing menthyl lactate, wherein the final menthyl lactate concentration is higher than that achievable by dissolving menthyl lactate in a neat solvent, by a) liquefying menthyl lactate, and b) combining the liquefied menthyl lactate with menthol carboxamide and the solvent, which solvent is acceptable for food, oral care or cosmetic use.
  • the present invention refers to a solution consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent, prepared by a method described above.
  • the solution of the invention does not contain any other flavour or fragrance compounds with exception of the solvent.
  • the solutions of the invention exhibit good storage stability. It has been observed that neither the menthyl lactate nor menthol carboxamide precipitates from the solution, even at relatively low storage temperatures, for example, down to about 4°C. Thus, a composition can be provided having a high concentration of the combined menthyl lactate and menthol carboxamide without having the aforementioned problems of solid products. Further, because the composition is in liquid form, it is considerably easier to formulate a product containing the solution, particularly a food product, an oral care product or a cosmetic product, than by using a powder or other solid mass which should be melted prior to use. Additionally, menthol carboxamide itself is known to the art to be a commercially-available coolant material, which exhibits little or no odour or flavour.
  • Preferred solvents for use in the present invention may be selected from any of those solvents that may be used in food, oral care or cosmetic applications. Most preferred as solvents are those selected from the group consisting of octyldodecanol, dipropylene glycol, propylene glycol, triglyceride, isopropyl myristate, olive oil, almond oil, hexyl laurate, alcohols, and mixtures thereof, as well as aqueous compositions containing one or more of the aforesaid solvents, (e.g. an aqueous alcoholic mixture containing 10% water).
  • solvents e.g. an aqueous alcoholic mixture containing 10% water.
  • solvent means a single solvent or a mixture of solvents. Different purity grades, such as food-grade and pharmaceutical-grade, are included.
  • nitrogen solvent means a solvent as defined above not comprising menthol carboxamide.
  • liquefying means a process step to make the solid menthyl lactate liquid by melting.
  • the menthyl lactate and menthol carboxamide may be added to an appropriate solvent to produce solutions containing from 1 to 99% by weight of the combined menthyl lactate and menthol carboxamide compounds, preferably 55% to 80% by weight, with the remaining balance being the solvent. More preferably, the inventive solutions contain from about 25 to 30% solvent, more particularly 27 to 29% solvent, with the remaining balance to 100% being the combined menthyl lactate and menthol carboxamide.
  • the ratio of menthyl lactate to menthol carboxamide may vary widely, dependent on the cooling properties sought. For example, whereas both compounds are known for their pronounced, or "high-impact" coolant effects, they have been observed to affect areas of the oral cavity differently. Menthyl lactate tends to target the front/middle of the mouth, whereas menthol carboxamide tends to target the back and roof of the mouth. The skilled formulator in the art is therefore able to combine an appropriate ratio of menthyl lactate to menthol carboxamide so to achieve any desired sensory effect as a matter of routine or by a few routine experiments, without recourse to inventive activity.
  • a shelf stable-solution of menthyl lactate and menthol carboxamide containing 10% to 20% by weight menthol carboxamide, more particularly 14% to 18% by weight menthol carboxamide.
  • a shelf-stable solution of menthyl lactate and menthol carboxamide containing 50% to 60% by weight of menthyl lactate, more particularly 55% to 60%, especially 55% to 57% by weight menthyl lactate.
  • the solutions of the present invention may be formed by combining menthyl lactate and menthol carboxamide and dissolving these compounds in one or more suitable solvents, particularly one or more of the preferred solvents recited herein.
  • menthyl lactate solid is first liquefied or melted at a temperature of about 40°C to 50°C.
  • Menthol carboxamide which is often commercially provided as fine powder, may be directly dissolved in the liquefied menthyl lactate. Thereafter, the combined menthyl lactate/ menthol carboxamide is dissolved in the solvent under suitable stirring to form shelf stable solutions therefrom.
  • the solution of the present invention is formed by dissolving menthol carboxamide in the solvent and thereafter, the liquefied menthyl lactate is combined with the menthol carboxamide solution under suitable stirring to form shelf-stable solutions therefrom.
  • the solutions of the present invention are provided in a liquid form that exhibits good shelf stability with little or no precipitation. This renders the solutions easy to store under conditions of varied humidity and temperature such as about 4°C to 25°C preferably to 20°C, and also renders them easy to handle and to formulate into all manner of food, oral care and cosmetic products. Solutions according to the present invention are therefore eminently suitable for admixture with food, oral care and cosmetic products in order to produce products with desirable cooling effects.
  • a further aspect of the present invention refers to a method of improving the solubility of menthyl lactate by liquefying menthyl lactate and combining the liquefied menthyl lactate with menthol carboxamide and a solvent.
  • a further aspect of the invention is a food, oral care or cosmetic product to which has been added a solution prepared according to the first aspect of the invention.
  • Such food, oral care or cosmetic products may be provided with the solution according to the present invention by any useful method, e.g., by simple addition to, and mixing into the food, oral care or cosmetic product of a useful amount of the solution according to the present invention.
  • the solutions of the present invention may be employed in a wide variety of food or oral care products, e.g., toothpastes, mouthwashes, chewing gums, confections, as well as in beverages.
  • the solutions of the present invention may also be employed in cosmetic products, for example, products for topical application such as shaving lotions, foams, creams, gels, after-shaves, shampoos, shower gels, foam baths and other compositions known for topical use.
  • the solutions of the present invention may be employed at levels sufficient to attain a combined amount of menthyl lactate and menthol caroboxamide of about 0.01 % to 1 % by weight, preferably from 0.06% to 0.5%, more preferably from about 0.06% to 0.45% by weight, based on the total weight of the food or oral care product.
  • the solutions of the present invention may be employed at levels sufficient to attain a combined amount of menthyl lactate and menthol carboxamide of about 0.01 % to 10% by weight, based on the total weight of the cosmetic product.
  • the skilled person may employ the inventive solutions in amounts outside the aforementioned ranges to achieve sensorial effects as may be desired.
  • menthyl lactate 57 parts by weight of menthyl lactate are warmed to 40 -50°C to liquefy the menthyl lactate. 14 parts by weight of menthol carboxamide are mixed into the liquefied menthyl lactate. Thereafter, the menthyl lactate/menthol carboxamide mixture is added to 29 parts by weight of propylene glycol (USP) in order to form a solution of menthyl lactate and menthol carboxamide in propylene glycol.
  • USP propylene glycol
  • the solution is allowed to cool and is stored. No precipitation is observed.
  • Example 1 The procedure of Example 1 is carried out using 18 parts by weight of menthol carboxamide, 55 parts by weight of menthyl lactate and 27 parts by weight of propylene glycol (USP). A solution is obtained that upon cooling and storage does not produce a precipitate.
  • menthyl lactate a 50% by weight solution of menthyl lactate was produced by first melting the menthyl lactate by heating to 40°C- 50°C, and thereafter mixing it with an appropriate amount of propylene glycol (USP). Upon cooling, a fine precipitate of menthyl lactate is observed.
  • USP propylene glycol
  • Example 1 The procedure of Example 1 is carried out using 5 parts by weight of menthol carboxamide, 65 parts by weight of menthyl lactate and 30 parts by weight of ethanol solution containing 10% by weight water. A solution is obtained that upon cooling and storage does not produce a precipitate.
  • Comparative Example 2 To illustrate the precipitation of menthyl lactate in a solvent, a 60% by weight solution of menthyl lactate was produced by first melting the menthyl lactate by heating to 40°C- 50°C, and thereafter mixing it with an appropriate amount of ethanol solution containing 10% by weight water. Upon cooling in the fridge overnight, a fine precipitate of menthyl lactate is observed.
  • a sensory test was carried out with a group of 10 trained panelists in order to evaluate the performance of the solutions of Example 1 and 2 as cooling agents. Panelists were asked to assess the intensity of coolant effect at certain time periods on a line scale of zero to one hundred. Panelists held toothpaste containing formulations of Example 1 (0.65% by weight based on total amount of the toothpaste) and Example 2 (0.45% by weight based on the total amount of the toothpaste) in their mouths for 90 seconds before spitting and rinsing. Panelists record the coolant sensation at rinse (time zero), 30s, 60s, 90s, 2min, 3min, 4, min, 5 min, 10 min, 15 min, 20 min, 25 min and 30 min.

Abstract

A solution consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent, such as propylene glycol, which solvent is acceptable for food, oral care or cosmetic products and a method of preparing it.

Description

Coolant Solutions and Compositions Comprising the Sameitle
This invention is concerned with compositions, and especially solutions comprising menthyl lactate and menthol carboxamide.
Menthyl lactate is an important ingredient that is valued for its coolant properties. Furthermore, given its virtual lack of odour and colour, it can be used in all manner of flavour and fragrance compositions to impart an intense and persistent cooling effect without affecting the balance of the fragrance or flavour accord.
It is commercially available as a white, low-melting point solid that is supplied as a solid mass that has to be physically broken down and melted before use in food or cosmetic applications. These physical properties make this compound difficult to work with. Consequently, attempts have been made in the art to provide the compound in a more convenient form. For example, in DE 19607278, reference is made to the problems of working with menthyl lactate and a new crystalline form of the material is disclosed as a solution to this problem. In this reference, it is disclosed that menthyl lactate can be mixed with a small amount of alkali or alkaline earth carbonate and recrystallised from acetone to provide menthyl lactate in fine crystal form. This crystalline form of menthyl lactate is currently commercially available. However, use of this crystalline form is not without problems.
Firstly, it is powder-like and, as with all powders, it must be handled with caution to avoid dust hazards associated therewith. Secondly, it is not always convenient or easy to mix the powder into food or into cosmetic formulation bases, which may be in a liquid or a paste-like form. To deal with this problem, formulators may solubilise the crystals using an acceptable solvent, before adding the solution to such a food product, oral care product or cosmetic product. However, this solubilization constitutes an extra processing step for the formulator, making it inconvenient and more costly to use. Thirdly, even though the menthyl lactate is provided in crystalline form, because of its low melting point, under certain storage conditions such as elevated temperature and/or high humidity, the crystalline menthyl lactate powder has a tendency to agglomerate. Therefore, for long term storage of the crystal form, it must be kept at relatively low temperatures and under conditions of low humidity.
DCCTΛTIΛI IMΛΪCLrrkDIC Accordingly, there remains a need to provide menthyl lactate in a form that is easy to use in further formulation operations and which remains stable in that form for long periods of storage, even under conditions of relatively high humidity and temperature.
Surprisingly, it has now been found that stable solutions of menthyl lactate can be obtained comprising a relative high amount of menthyl lactate, if the menthyl lactate is combined with, or co-dissolved with menthol carboxamide.
Therefore, in a first aspect the present invention provides a method of preparing a solution containing menthyl lactate, wherein the final menthyl lactate concentration is higher than that achievable by dissolving menthyl lactate in a neat solvent, by a) liquefying menthyl lactate, and b) combining the liquefied menthyl lactate with menthol carboxamide and the solvent, which solvent is acceptable for food, oral care or cosmetic use.
In a second aspect the present invention refers to a solution consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent, prepared by a method described above. Preferably, the solution of the invention does not contain any other flavour or fragrance compounds with exception of the solvent.
The solutions of the invention exhibit good storage stability. It has been observed that neither the menthyl lactate nor menthol carboxamide precipitates from the solution, even at relatively low storage temperatures, for example, down to about 4°C. Thus, a composition can be provided having a high concentration of the combined menthyl lactate and menthol carboxamide without having the aforementioned problems of solid products. Further, because the composition is in liquid form, it is considerably easier to formulate a product containing the solution, particularly a food product, an oral care product or a cosmetic product, than by using a powder or other solid mass which should be melted prior to use. Additionally, menthol carboxamide itself is known to the art to be a commercially-available coolant material, which exhibits little or no odour or flavour.
Preferred solvents for use in the present invention may be selected from any of those solvents that may be used in food, oral care or cosmetic applications. Most preferred as solvents are those selected from the group consisting of octyldodecanol, dipropylene glycol, propylene glycol, triglyceride, isopropyl myristate, olive oil, almond oil, hexyl laurate, alcohols, and mixtures thereof, as well as aqueous compositions containing one or more of the aforesaid solvents, (e.g. an aqueous alcoholic mixture containing 10% water).
As used herein, "solvent" means a single solvent or a mixture of solvents. Different purity grades, such as food-grade and pharmaceutical-grade, are included.
As used herein, "neat solvent" means a solvent as defined above not comprising menthol carboxamide.
As used herein, "liquefying" means a process step to make the solid menthyl lactate liquid by melting.
The menthyl lactate and menthol carboxamide may be added to an appropriate solvent to produce solutions containing from 1 to 99% by weight of the combined menthyl lactate and menthol carboxamide compounds, preferably 55% to 80% by weight, with the remaining balance being the solvent. More preferably, the inventive solutions contain from about 25 to 30% solvent, more particularly 27 to 29% solvent, with the remaining balance to 100% being the combined menthyl lactate and menthol carboxamide.
The ratio of menthyl lactate to menthol carboxamide may vary widely, dependent on the cooling properties sought. For example, whereas both compounds are known for their pronounced, or "high-impact" coolant effects, they have been observed to affect areas of the oral cavity differently. Menthyl lactate tends to target the front/middle of the mouth, whereas menthol carboxamide tends to target the back and roof of the mouth. The skilled formulator in the art is therefore able to combine an appropriate ratio of menthyl lactate to menthol carboxamide so to achieve any desired sensory effect as a matter of routine or by a few routine experiments, without recourse to inventive activity.
In a particularly preferred embodiment, there is provided a shelf stable-solution of menthyl lactate and menthol carboxamide containing 10% to 20% by weight menthol carboxamide, more particularly 14% to 18% by weight menthol carboxamide. In a particularly preferred embodiment there is provided a shelf-stable solution of menthyl lactate and menthol carboxamide containing 50% to 60% by weight of menthyl lactate, more particularly 55% to 60%, especially 55% to 57% by weight menthyl lactate.
The solutions of the present invention may be formed by combining menthyl lactate and menthol carboxamide and dissolving these compounds in one or more suitable solvents, particularly one or more of the preferred solvents recited herein. Conveniently, menthyl lactate solid is first liquefied or melted at a temperature of about 40°C to 50°C. Menthol carboxamide, which is often commercially provided as fine powder, may be directly dissolved in the liquefied menthyl lactate. Thereafter, the combined menthyl lactate/ menthol carboxamide is dissolved in the solvent under suitable stirring to form shelf stable solutions therefrom.
Alternatively, the solution of the present invention is formed by dissolving menthol carboxamide in the solvent and thereafter, the liquefied menthyl lactate is combined with the menthol carboxamide solution under suitable stirring to form shelf-stable solutions therefrom.
As stated hereinabove, the solutions of the present invention are provided in a liquid form that exhibits good shelf stability with little or no precipitation. This renders the solutions easy to store under conditions of varied humidity and temperature such as about 4°C to 25°C preferably to 20°C, and also renders them easy to handle and to formulate into all manner of food, oral care and cosmetic products. Solutions according to the present invention are therefore eminently suitable for admixture with food, oral care and cosmetic products in order to produce products with desirable cooling effects.
Accordingly, a further aspect of the present invention refers to a method of improving the solubility of menthyl lactate by liquefying menthyl lactate and combining the liquefied menthyl lactate with menthol carboxamide and a solvent.
Furthermore, it has surprisingly been found that the cooling effects of the combined menthyl lactate and menthol carboxamide solutions taught herein are often not merely additive. It has been unexpectedly found that, when solutions of the present invention were tested by trained panelists in sensory evaluations against the individual menthyl lactate or menthol carboxamide compounds, synergistic cooling effects were often observed. This surprising effect is more fully described in the Examples presented below.
A further aspect of the invention is a food, oral care or cosmetic product to which has been added a solution prepared according to the first aspect of the invention. Such food, oral care or cosmetic products may be provided with the solution according to the present invention by any useful method, e.g., by simple addition to, and mixing into the food, oral care or cosmetic product of a useful amount of the solution according to the present invention.
The solutions of the present invention may be employed in a wide variety of food or oral care products, e.g., toothpastes, mouthwashes, chewing gums, confections, as well as in beverages. The solutions of the present invention may also be employed in cosmetic products, for example, products for topical application such as shaving lotions, foams, creams, gels, after-shaves, shampoos, shower gels, foam baths and other compositions known for topical use.
For use in food and oral care products, the solutions of the present invention may be employed at levels sufficient to attain a combined amount of menthyl lactate and menthol caroboxamide of about 0.01 % to 1 % by weight, preferably from 0.06% to 0.5%, more preferably from about 0.06% to 0.45% by weight, based on the total weight of the food or oral care product. For use in cosmetic products, the solutions of the present invention may be employed at levels sufficient to attain a combined amount of menthyl lactate and menthol carboxamide of about 0.01 % to 10% by weight, based on the total weight of the cosmetic product. However, it is understood that the skilled person may employ the inventive solutions in amounts outside the aforementioned ranges to achieve sensorial effects as may be desired.
The following examples illustrate various aspects of the invention.
Example 1
57 parts by weight of menthyl lactate are warmed to 40 -50°C to liquefy the menthyl lactate. 14 parts by weight of menthol carboxamide are mixed into the liquefied menthyl lactate. Thereafter, the menthyl lactate/menthol carboxamide mixture is added to 29 parts by weight of propylene glycol (USP) in order to form a solution of menthyl lactate and menthol carboxamide in propylene glycol.
The solution is allowed to cool and is stored. No precipitation is observed.
Example 2
The procedure of Example 1 is carried out using 18 parts by weight of menthol carboxamide, 55 parts by weight of menthyl lactate and 27 parts by weight of propylene glycol (USP). A solution is obtained that upon cooling and storage does not produce a precipitate.
Comparative Example 1
To illustrate the precipitation of menthyl lactate in a solvent, a 50% by weight solution of menthyl lactate was produced by first melting the menthyl lactate by heating to 40°C- 50°C, and thereafter mixing it with an appropriate amount of propylene glycol (USP). Upon cooling, a fine precipitate of menthyl lactate is observed.
Example 3
The procedure of Example 1 is carried out using 5 parts by weight of menthol carboxamide, 65 parts by weight of menthyl lactate and 30 parts by weight of ethanol solution containing 10% by weight water. A solution is obtained that upon cooling and storage does not produce a precipitate.
Comparative Example 2 To illustrate the precipitation of menthyl lactate in a solvent, a 60% by weight solution of menthyl lactate was produced by first melting the menthyl lactate by heating to 40°C- 50°C, and thereafter mixing it with an appropriate amount of ethanol solution containing 10% by weight water. Upon cooling in the fridge overnight, a fine precipitate of menthyl lactate is observed.
Example 4
A sensory test was carried out with a group of 10 trained panelists in order to evaluate the performance of the solutions of Example 1 and 2 as cooling agents. Panelists were asked to assess the intensity of coolant effect at certain time periods on a line scale of zero to one hundred. Panelists held toothpaste containing formulations of Example 1 (0.65% by weight based on total amount of the toothpaste) and Example 2 (0.45% by weight based on the total amount of the toothpaste) in their mouths for 90 seconds before spitting and rinsing. Panelists record the coolant sensation at rinse (time zero), 30s, 60s, 90s, 2min, 3min, 4, min, 5 min, 10 min, 15 min, 20 min, 25 min and 30 min.
Toothpastes containing a solution produced according to Example 1 or Example 2 both outperformed toothpastes containing only menthyl lactate or containing only menthol carboxamide.

Claims

Claims
1. A method of preparing a solution of menthyl lactate, wherein the final concentration of menthyl lactate is higher than that achievable by dissolving menthyl lactate in a neat solvent, by a) liquefying menthyl lactate; and b) combining the liquefied menthyl lactate with menthol carboxamide and the solvent.
2. A method according to claim 1 , in which the menthol carboxamide is added to the liquefied menthyl lactate and this liquid mixture is then dissolved in the solvent.
3. A method according to claim 1 , in which the menthol carboxamide is first dissolved in the solvent, and this solution is then mixed with the liquefied menthyl lactate.
4. A method according to any of the preceding claims, wherein the solvent is selected from the group consisting of octyldodecanol, dipropylene glycol, propylene glycol, triglyceride, isopropyl myristate, olive oil, almond oil, hexyl laurate and alcohol.
5. A solution prepared by the method of any one of the preceding claims, consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent.
6. A solution consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent, characterized in that the final concentration of menthyl lactate is higher than that achievable by dissolving menthyl lactate alone in the solvent.
7. A solution according to claim 5 or claim 6 wherein the solvent is propylene glycol.
8. A solution according to claim 7 wherein the propylene glycol is present in amounts of 25% to 30% by weight of the total solution.
9. A solution according to claim 5 or claim 6 wherein the menthyl lactate is present in amounts of from 50% to 60% by weight of the total solution.
10. A solution according to claim 5 of claim 6 wherein the menthol carboxamide is present in amounts of from 10% to 20% by weight of the total solution.
11. A food or oral care or cosmetic composition comprising a solution as defined in one of the claims 5 to 10.
12. A method of improving the solubility of menthyl lactate comprising the steps of c) liquefying menthyl lactate; and d) combining the liquefied menthyl lactate with menthol carboxamide and the solvent.
13. A solution consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent.
PCT/CH2003/000703 2002-10-28 2003-10-27 Coolant solutions and compositions comprising the sameitle WO2004037764A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002497910A CA2497910A1 (en) 2002-10-28 2003-10-27 Coolant solutions and compositions comprising the same
US10/532,514 US8093290B2 (en) 2002-10-28 2003-10-27 Coolant solutions and compositions comprising the same
AU2003271498A AU2003271498A1 (en) 2002-10-28 2003-10-27 Coolant solutions and compositions comprising the sameitle
EP03753207.4A EP1556332B1 (en) 2002-10-28 2003-10-27 Coolant solutions and compositions comprising the same
BRPI0315686-9A BR0315686B1 (en) 2002-10-28 2003-10-27 Solutions consisting of menthol lactam and menthol carboxamide, their method of preparation, food composition, oral care or cosmetic, as well as method for improving menthol lactate solubility

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42167302P 2002-10-28 2002-10-28
US60/421,673 2002-10-28

Publications (2)

Publication Number Publication Date
WO2004037764A1 true WO2004037764A1 (en) 2004-05-06
WO2004037764A8 WO2004037764A8 (en) 2004-07-22

Family

ID=32176734

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2003/000703 WO2004037764A1 (en) 2002-10-28 2003-10-27 Coolant solutions and compositions comprising the sameitle

Country Status (7)

Country Link
US (1) US8093290B2 (en)
EP (1) EP1556332B1 (en)
CN (1) CN1300095C (en)
AU (1) AU2003271498A1 (en)
BR (1) BR0315686B1 (en)
CA (1) CA2497910A1 (en)
WO (1) WO2004037764A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006037448A1 (en) * 2004-10-04 2006-04-13 Coty Deutschland Gmbh Cosmetic cooling composition
US7482378B2 (en) 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
WO2010019729A1 (en) * 2008-08-15 2010-02-18 The Procter & Gamble Company Solution of menthane carboxamides for use in consumer products
WO2012098342A1 (en) * 2011-01-18 2012-07-26 Paget, Hugh, Charles, Edward (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
US8426643B2 (en) 2008-08-15 2013-04-23 The Procter & Gamble Company Synthesis of cyclohexane derivatives useful as sensates in consumer products
US8529915B2 (en) 2010-03-20 2013-09-10 Edward T. Wei (R)-(-)-1,2-propanediol compositions and methods
US9662286B2 (en) 2012-11-27 2017-05-30 Basf Se Composition of menthol and menthyl lactate, its preparation and its use as a cooling, flavouring and/or fragrance agent
US9918915B2 (en) 2007-11-20 2018-03-20 The Procter & Gamble Company Personal care compositions providing enhanced cooling sensation
US10392371B2 (en) 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8
WO2020033669A1 (en) 2018-08-10 2020-02-13 Firmenich Incorporated Antagonists of t2r54 and compositions and uses thereof

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
BRPI0416770B1 (en) 2003-11-21 2014-05-13 Givaudan Sa N-REPLACED CARBOSAMIDATED P-MENTAN
JP2005310310A (en) * 2004-04-23 2005-11-04 Sanyo Electric Co Ltd Tracking balance adjustment device
KR20070107083A (en) * 2005-03-01 2007-11-06 지보당 에스아 Menthane carboxamide derivatives having cooling properties
GB0504194D0 (en) 2005-03-02 2005-04-06 Givaudan Sa Organic compounds
WO2007019719A1 (en) 2005-08-15 2007-02-22 Givaudan Sa Cooling compounds
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
BRPI0721140A2 (en) * 2006-12-20 2014-04-01 Givaudan Nederland Services Bv P-MENTANE-3-N-REPLACED CARBOXAMIDE AND USES OF THE SAME.
PL1986473T3 (en) * 2007-04-03 2017-07-31 Tsinghua University Organic electroluminescent device
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
CN101419465B (en) * 2007-10-26 2010-04-07 中国科学院沈阳自动化研究所 SPM probe enhancement work method
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2009089641A1 (en) * 2008-01-17 2009-07-23 Givaudan Sa Benzimidazole derivatives and their use as cooling agents
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US8664261B2 (en) 2009-05-05 2014-03-04 Givaudan S.A. Organic compounds having cooling properties
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (en) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Topical tetracycline compositions.
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
GB201103103D0 (en) 2011-02-23 2011-04-06 Givaudan Sa Organic compounds
CN102872476B (en) * 2012-08-10 2016-08-03 泉州市晋江恒安卫生科技有限公司 Freshener, freshener preparation method and disposable sanitary articles
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
GB201703136D0 (en) * 2017-02-27 2017-04-12 Givaudan Sa Compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1351761A (en) * 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
DE19607278A1 (en) 1996-02-27 1997-08-28 Haarmann & Reimer Gmbh Stabilized lactic acid ethyl ester
WO1999013734A1 (en) 1997-09-18 1999-03-25 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193936A (en) * 1971-02-04 1980-03-18 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
US7173146B1 (en) * 2005-10-13 2007-02-06 Millennium Specialty Chemicals, Inc. Menthyl lactate process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1351761A (en) * 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
DE19607278A1 (en) 1996-02-27 1997-08-28 Haarmann & Reimer Gmbh Stabilized lactic acid ethyl ester
WO1999013734A1 (en) 1997-09-18 1999-03-25 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482378B2 (en) 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
WO2006037448A1 (en) * 2004-10-04 2006-04-13 Coty Deutschland Gmbh Cosmetic cooling composition
US9918915B2 (en) 2007-11-20 2018-03-20 The Procter & Gamble Company Personal care compositions providing enhanced cooling sensation
US8754259B2 (en) 2008-08-15 2014-06-17 The Procter & Gamble Company Synthesis of cyclohexane derivatives useful as sensates in consumer products
WO2010019729A1 (en) * 2008-08-15 2010-02-18 The Procter & Gamble Company Solution of menthane carboxamides for use in consumer products
US8277824B2 (en) 2008-08-15 2012-10-02 The Procter & Gamble Company Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products
US8426643B2 (en) 2008-08-15 2013-04-23 The Procter & Gamble Company Synthesis of cyclohexane derivatives useful as sensates in consumer products
US8529915B2 (en) 2010-03-20 2013-09-10 Edward T. Wei (R)-(-)-1,2-propanediol compositions and methods
WO2012098342A1 (en) * 2011-01-18 2012-07-26 Paget, Hugh, Charles, Edward (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
CN103458928A (en) * 2011-01-18 2013-12-18 魏德烽 (R)-1,2-propanediol for use as solvent in therapeutic cooling agent compositions
US9662286B2 (en) 2012-11-27 2017-05-30 Basf Se Composition of menthol and menthyl lactate, its preparation and its use as a cooling, flavouring and/or fragrance agent
US10392371B2 (en) 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8
WO2020033669A1 (en) 2018-08-10 2020-02-13 Firmenich Incorporated Antagonists of t2r54 and compositions and uses thereof

Also Published As

Publication number Publication date
CA2497910A1 (en) 2004-05-06
BR0315686B1 (en) 2014-04-29
CN1300095C (en) 2007-02-14
AU2003271498A8 (en) 2004-05-13
CN1692096A (en) 2005-11-02
WO2004037764A8 (en) 2004-07-22
EP1556332B1 (en) 2016-10-05
EP1556332A1 (en) 2005-07-27
AU2003271498A1 (en) 2004-05-13
BR0315686A (en) 2005-09-06
US8093290B2 (en) 2012-01-10
US20060051301A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
US8093290B2 (en) Coolant solutions and compositions comprising the same
US4465661A (en) Oral product having improved taste
NO138014B (en) AROMA AND FRESH IMPROVEMENT PREPARATIONS
JP2013520541A (en) Method for producing a composition comprising a compound containing vanillin and ethyl vanillin, composition obtained thereby and use thereof
KR100769581B1 (en) Cosmetics composition for crackling candy
JP4803889B2 (en) Non-aqueous toothpaste
JP2589761B2 (en) Cosmetic additives
JP2610444B2 (en) Oral composition
FR2477412A1 (en) COSMETIC COMPOSITIONS FOR SKIN CARE IN THE FORM OF CREAM OR MILK
CA2344078C (en) Non-crystallizing liquid xylitol compositions and co-hydrogenation processes for making same
JP2002114656A (en) Base material for composition for oral cavity and composition for oral cavity
US5352693A (en) Preservative mixtures
JP2002302429A (en) Composition for oral cavity
JPH1112241A (en) N-long-chain acylamino acid-containing detergent composition
KR100772210B1 (en) Stable tooth-foam composition for brushing teeth
JP2002212041A (en) Composition for oral cavity
JPH0881344A (en) Composition for oral cavity
JP3836051B2 (en) Skin external preparation containing arbutin
JPS6089402A (en) Germicide composition
KR100676265B1 (en) Clearly concentrated shampoo composition
JPH03112915A (en) Whitening agent
JPH01238521A (en) Liquid skin detergent composition
WO2018154102A1 (en) Cooling compositions
JPH11322581A (en) Cleaning agent composition
JPH0645525B2 (en) Hair treatment agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WR Later publication of a revised version of an international search report
REEP Request for entry into the european phase

Ref document number: 2003753207

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003753207

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2497910

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 20038A07205

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2006051301

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10532514

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 753/CHENP/2005

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2003753207

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10532514

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP